Karen Winkfield

Last updated
Karen Winkfield
Born1970 (age 5253)
Alma mater Binghamton University
Duke University School of Medicine
Scientific career
FieldsRadiation oncology, health equity
Institutions Atrium Health Wake Forest Baptist
Vanderbilt University
Website drkarenwinkfield.com

Karen Marie Winkfield (born 1970) is an American radiation oncologist, physician-scientist, and implementation scientist. She is the Ingram Professor of Cancer Research at Vanderbilt University School of Medicine.

Contents

Early life and education

Winkfield was born in 1970 [1] to a family of Jehovah's Witnesses who were opposed to formal education. [2]

Winkfield completed a B.S. in biochemistry at Binghamton University. She earned a Ph.D. (2004) in pathology and M.D. (2005) from Duke University School of Medicine. [3] [4] Winkfield was the second black woman to complete the medical scientist training program at Duke University. [4] She completed a radiation oncology residency at Harvard University. [5]

Career

Winfield was an associate director for community outreach and engagement and director of the office of cancer health equity at Atrium Health Wake Forest Baptist. [5] In 2020, Winkfield joined Vanderbilt University. [5] She is the executive director of the Meharry-Vanderbilt Alliance, Ingram Professor of Cancer Research, and a professor of radiation oncology at Vanderbilt University Medical Center. [3]

Winkfield is the cofounder and director of the Association of Black Radiation Oncologists. [5] She is an implementation scientist focused on using her experience with community engagement to improve health equity. Winkfield co-leads the Inclusive Participation Workgroup of the NIH CEAL teams against COVID-19 disparities. [6]

In September 2021, Winkfield was appointed by U.S. president Joe Biden to a six-year term on the National Cancer Advisory Board. [5] [6] She was also recognized as one of the 100 Influential Women in Oncology by OncoDaily. [7]

Personal life

Winkfield was married to Jeffrey Walker. Walker was diagnosed with type 2 diabetes in 2003 and passed away in 2018 from complications of the disease. His medical journey influenced Winkfield to pursue patient advocacy. [2]

See also

Related Research Articles

M. Krishnan Nair was an Indian oncologist. He was the founding director of the Regional Cancer Centre, Thiruvananthapuram, a director of the S.U.T. Institute of Oncology, and Trivandrum Cancer Center(TCC), part of SUT Royal Hospital in Thiruvananthapuram (Trivandrum) and a professor at the Amrita Institute of Medical Sciences & Research in Kochi. The Government of India awarded him the fourth highest civilian award of the Padma Shri in 2001 for his contributions in the cancer care field.

<span class="mw-page-title-main">Stephen Hahn</span> American physician (born 1960)

Stephen Michael Hahn is an American physician who served as the Commissioner of Food and Drugs from 2019 to 2021. Before becoming Commissioner, he was an oncologist serving as Chief Medical Executive of the MD Anderson Cancer Center. In 2021 he became Chief medical officer at the venture capital firm that launched Moderna.

Brigid L. M. Hogan FRS is a British developmental biologist noted for her contributions to mammalian development, stem cell research and transgenic technology and techniques. She is currently a Professor in the Department of Cell Biology at Duke University, Born in the UK, she became an American citizen in 2000.

<span class="mw-page-title-main">Olufunmilayo Olopade</span> Nigerian physician

Olufunmilayo I. Olopade born in the year 1957, is a Nigerian hematology oncologist, Associate Dean for Global Health and Walter L. Palmer, Distinguished Service Professor in Medicine and Human Genetics at the University of Chicago. She also serves as director of the University of Chicago Hospital's Cancer Risk Clinic.

Professor Minesh P. Mehta, MD, FASTRO, is an American radiation oncologist and physician-scientist of Indian origin, Ugandan birth, Zambian Schooling and American Training, who contributed to the field of oncology for more than two and half decades.

Ralph R. Weichselbaum is an American physician specializing in radiation oncology, a member of the Institute of Medicine of the National Academy of Sciences, Ludwig professor, He is Daniel K. Ludwig Distinguished Service Professor of Radiation Oncology and Chairman, Department of Radiation and Cellular Oncology, at the University of Chicago Pritzker School of Medicine, and Head of the University of Chicago Center for Radiation Therapy, and the director of the Chicago Tumor Institute. Weichselbaum is also Co- Director of the Ludwig Center for Metastasis Research at the University of Chicago.

<span class="mw-page-title-main">Consuelo H. Wilkins</span>

Consuelo H. Wilkins is an American physician, biomedical researcher, and health equity expert. She is Senior Vice President and Senior Associate Dean for Health Equity and Inclusive Excellence at Vanderbilt University Medical Center. She is a professor of medicine in the Department of Medicine, Division of Geriatrics at Vanderbilt University School of Medicine and has a joint appointment at Meharry Medical College. She additionally serves as one of the principal investigators of the Vanderbilt Clinical and Translational Science Award, Director of the Meharry-Vanderbilt Community Engaged Research Core (CTSA) and as vice president for Health Equity at Vanderbilt University Medical Center.

Edith A. Pérez is a Puerto Rican hematologist-oncologist. She is the Serene M. and Frances C. Durling Professor of Medicine at the Mayo Clinic Alix School of Medicine.

Walter "Wally" J. Curran, Jr. is an American radiation oncologist specializing in the treatment of malignant brain tumors and locally advanced lung cancer.

Christine M. Lovly is an associate professor of medicine at Vanderbilt University. Her research involves the development of novel treatment strategies for ALK positive lung cancer.

<span class="mw-page-title-main">David Gius</span> American physician-scientist

David R. Gius is an American physician-scientist the Zell Family Scholar Professor, Women's Cancer Research Program director, and Vice Chair of Translational Research at Northwestern University's Feinberg School of Medicine Department of Radiation Oncology and Pharmacology. His research focuses into the mechanistic connection between aging, cellular and/or mitochondrial metabolism, and carcinogenesis focusing on the Sirtuin gene family.

<span class="mw-page-title-main">Reshma Jagsi</span> American radiation oncologist

Reshma Jagsi is an American Radiation oncologist. She is the Lawrence W. Davis Professor and Chair in the Department of Radiation Oncology and Senior Faculty Fellow in the Center for Ethics at Emory University. Overall, she is the author of over 450 published articles in peer-reviewed medical journals and continues scholarly research in three primary areas of interest: breast cancer, bioethics, and gender equity, with the support of grants from the National Institutes of Health (NIH), the Doris Duke Charitable Foundation, and the Susan G. Komen Foundation, for which she serves as a Senior Scholar.

<span class="mw-page-title-main">Worta McCaskill-Stevens</span> American physician-scientist (died 2023)

Worta J. McCaskill-Stevens was an American physician-scientist and medical oncologist specialized in cancer disparities research, management of comorbidities within clinical trials, and molecular research for cancer prevention interventions. She was chief of the community oncology and prevention trials research group at the National Cancer Institute.

Ami Bhatt is an American physician-scientist who studies the link between blood cancers and the human gut microbiome. She holds associate professorships in Genetics and Medicine (Hematology) at Stanford University. She is a member of Stanford Bio-X, the Stanford Cancer Institute, Stanford Maternal & Child Health Research Institute (MCHRI), and Stanford ChEM-H. In addition, Bhatt is the co-founder of Global Oncology Inc., a nonprofit focused on providing quality oncologic treatment in resource-constrained settings.

Lori Jo Pierce is an American radiation oncologist and 57th President of the American Society of Clinical Oncology. She is a Full Professor and Vice Provost for Academic and Faculty Affairs at the University of Michigan. Her research focuses on the use of radiotherapy in the multi-modality treatment of breast cancer, with emphasis on intensity modulated radiotherapy in node positive breast cancer, the use of radiosensitizing agents, and the outcomes of women treated with radiation for breast cancer who are carriers of a BRCA1/2 breast cancer susceptibility gene.

Maura Lianne Gillison is an American medical oncologist and molecular epidemiologist. She is credited as the first investigator to establish a connection between HPV and oral cancer.

Eric Reese Fearon is an American oncologist. He is the Emanuel N. Maisel Professor of Oncology at the University of Michigan and director of the University of Michigan Rogel Cancer Center.

Nilofer Saba Azad is an American oncologist and physician-scientist specialized in gastrointestinal, colorectal, cholangiocarcinoma, and pancreaticobiliary cancers. She is a professor at the Johns Hopkins School of Medicine and oversees clinical trials at the Sidney Kimmel Comprehensive Cancer Center.

Carol L. Brown is the Nicholls-Biondi Chair for Health Equity at Memorial Sloan Kettering Cancer Center and a professor at Weill Cornell Medical College. She is a surgeon known for her work on gynecological cancers.

W. Kimryn Rathmell is an American physician-scientist whose work focuses on the research and treatment of patients with kidney cancers. She is the Hugh Jackson Morgan Professor and Chair of the Department of Medicine at Vanderbilt University Medical Center (VUMC), and Physician-in-Chief for Vanderbilt University Adult Hospital and Clinics in Nashville, Tennessee. On Nov. 17, 2023, Rathmell was appointed Director of the National Cancer Institute.

References

  1. "VIAF". Virtual International Authority File. Retrieved 2021-09-25.
  2. 1 2 Watson, Stephanie (September 25, 2018). "Karen M. Winkfield, MD, PhD: 2018 Health Heroes, Advocate". WebMD. Retrieved 2021-09-26.
  3. 1 2 "Winkfield [193101] | Vanderbilt-Ingram Cancer Center". www.vicc.org. Retrieved 2021-09-26.
  4. 1 2 "Karen Winkfield, PhD'04, MD'05, HS'05-'06 | Duke School of Medicine". medschool.duke.edu. Archived from the original on 2021-09-26. Retrieved 2021-09-26.
  5. 1 2 3 4 5 Wilemon, Tom (2021-09-18). "President Biden Appoints MVA Executive Director to National Cancer Advisory Board". The Tennessee Tribune. Retrieved 2021-09-26.
  6. 1 2 "President Biden Appoints Members to National Cancer Advisory Board". The White House. 2021-09-15. Retrieved 2021-09-26.PD-icon.svg This article incorporates text from this source, which is in the public domain .
  7. "100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023". oncodaily.com. 14 October 2023.